- €580.70m
- €686.81m
- €615.82m
- 76
- 53
- 88
- 87
R2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 390 | 400 | 491 | 617 | 616 |
Cost of Revenue | |||||
Gross Profit | 140 | 147 | 173 | 208 | 217 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 368 | 385 | 461 | 566 | 569 |
Operating Profit | 22 | 15.5 | 30.6 | 51.6 | 46.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 20.6 | 11.9 | 30.6 | 59 | 36.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18.3 | 10.7 | 24.8 | 49.1 | 31.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 17.5 | 9.88 | 23.7 | 47.7 | 29.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17.5 | 9.88 | 23.7 | 47.7 | 29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.982 | 0.466 | 1.07 | 1.81 | 1.38 |
Dividends per Share |